Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Boundless Bio Inc (BOLD)

Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Boundless Bio Updates Clinical Trial Progress, Leadership Changes, and Future Development Plans Quiver Quantitative, Inc. - Fri Dec 13, 1:24AM CST

Boundless Bio announces leadership changes, halts BBI-825 trial, advances third ecDTx program, and extends operational runway to 2027.Quiver AI SummaryBoundless Bio has announced it will not advance BBI-825...

BOLD : 2.59 (+2.78%)
Boundless Bio Announces Pipeline and Leadership Updates GlobeNewswire - Thu Dec 12, 3:01PM CST

BOLD : 2.59 (+2.78%)
Boundless Bio to Participate in the Piper Sandler Healthcare Conference GlobeNewswire - Mon Nov 25, 6:00AM CST

BOLD : 2.59 (+2.78%)
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights GlobeNewswire - Thu Nov 7, 3:01PM CST

BOLD : 2.59 (+2.78%)
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference GlobeNewswire - Tue Nov 5, 6:00AM CST

BOLD : 2.59 (+2.78%)
Boundless Bio Announces Departure of Chief Financial Officer GlobeNewswire - Mon Oct 14, 7:00AM CDT

BOLD : 2.59 (+2.78%)
Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 Newswire.ca - Wed May 1, 9:05AM CDT

/CNW/ -- USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of...

BIOV.CN : 0.0650 (+8.33%)
BVAXF : 0.0475 (+2.15%)
MRNA : 39.39 (-0.43%)
BOLD : 2.59 (+2.78%)
IBRX : 2.62 (-1.87%)
MGNX : 3.18 (unch)
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses BayStreet.ca - Wed May 1, 8:54AM CDT

USA News Group – An alarming trend is happening around the world, where tens of millions of progressively younger people are being diagnosed with of cancer. A new report from the American Cancer Society...

BRX : 27.40 (+1.14%)
BIOV.CN : 0.0650 (+8.33%)
BVAXF : 0.0475 (+2.15%)
MRNA : 39.39 (-0.43%)
BOLD : 2.59 (+2.78%)
IBRX : 2.62 (-1.87%)
MGNX : 3.18 (unch)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot